Organizing Committee Members Series of - Chronic Diseases Conferences
Marina Komaroff, Dr.PH, MPH, MS is a Director of Biostatistics department at Noven Pharmaceuticals, which is a partner company of Hisamitsu in Tokyo, Japan. For the past 15 years, she has worked with research physicians and epidemiologists on the development and analysis of randomized clinical trials testing the efficacy and safety of investigational new drugs. Her major responsibility is collaborating with clinicians and regulatory management on statistical strategy and communication with the Federal Drug Administration (FDA) about the research methods and statistical analyses that must be reviewed, monitored and approved by the FDA before a new drug can be licensed for sale. She earned Doctorate Degree in Public Health from State University of New York (SUNY) Downstate Medical Center, Epidemiology and Biostatistics department; Master of Public Health degree from Columbia University Mailman School of Public Health. She is a fluent in Russian and hold a masterâ€™s in science from Saint Petersburg University (Russia) where she majored in applied mathematics. She is a member of American Public Health Association (APHA) and American Statistical Association (ASA); and have presented posters and papers at many professional conferences. She is a â€œBest Paperâ€ winner from PharmaSUG conferences in 2017 and 2018 years.
Marina Komaroff(Research Area)
Her research area focuses on Clinical Trails, Biostatistics, Epidemiology, Chronic Diseases and Public Health.
Umesh Prabhu is Currently working as Medical Adviser for Edgehill University for international medical recruitment, Patron of AvMA (Charity which helps patients who have suffered due to â€˜Medical Negligence), also Member of Patient Safety Advisory committee of Datix. After his graduation in India Dr Prabhu came to the UK in 1982. He then trained in Paediatrics at Oxford, Edinburgh and Leeds and in 1992 was appointed as a Consultant Paediatrician to the Bury NHS Trust. In 1998 he was appointed as the Medical Director of Bury Trust. He was a Non-executive member of the UK National Patient Safety Agency from 2001-2003. He was a National Adviser to the National Clinical Assessment Service of UK from 2003 to 2015. He also held the post of Medical Director of Wrightington, Wigan and Leigh FT, Greater Manchester, UK from 2010 to 2017. He has given more than 200 lectures and conducted many workshops for doctors nationally and internationally on patient safety, quality, why doctors make mistakes, professional regulation, value-based leadership, clinical governance and so on and advised and helped more than 500 doctors, mostly Indian doctors in UK.
Umesh Prabhu(Research Area)
His special interest is medical errors and patient safety.
Institute of Cellular Pharmacology
Dr Manuele Biazzo is the Research Director of the Institute of Cellular Pharmacology (ICP Ltd). He obtained an M.Sc. and B.Sc. in Medical Biotechnology (cum laude) at the University of Siena (Italy). He also obtained a PhD in Molecular and Industrial Biology (University of Bologna Italy) and a Master in Business Administration at the Anglia Ruskin University. He has worked in Novartis Vaccine before moving to Malta and accept the role of Director at ICP. This company has always investigated the pathogenesis of osteoporosis and the role that natural extract originated from marine algae could have to treat and prevent them. On September 7, 2018, the Institute of Cellular Pharmacology has been recognized by the French Government as an Official Research Centre that can carry out any research activity in behalf of any French companies. This recognition has been awarded thanks to the work Dr Biazzo developed on the human papilloma virus (HPV) infection together with Dott. Monda. Dr Biazzo is also managing the first virology laboratory in Malta working on human papilloma virus and human cytomegalovirus (beside other animal viruses). His experience as a Director of a research company and his experience as researcher in Novartis Vaccines and part time Lecture increased tremendously his ability to transmit the scientific knowledge to students and professionals. For this reason he has recently submitted a successful application to Maltese NCFHE Higher Education Institution License for the â€˜â€™Institute of Cellular Pharmacology Training Academyâ€, where he has the role of Academy Head.
Manuele Biazzo(Research Area)
His research interest includes cellular and molecular biology.
Dipak Ramji is Professor of Cardiovascular Science at the School of Biosciences in Cardiff University. He received his BSc (Hons) degree (Biochemistry) and his PhD (Molecular Biology) from the University of Leeds. This was followed by post-doctoral research at the European Molecular Biology Laboratory (Heidelberg) and the Istituto di Ricerche di Biologia Molecolare P. Angeletti (Rome) with fellowships from the Royal Society and the EU. He joined Cardiff University in 1992 and completed 25 years of service in August 2017. His research is focused on understanding how the immune and inflammatory responses regulate cellular processes in heart disease with the goal of attaining deeper mechanistic insight and identifying preventative/therapeutic agents. His research has been funded by several organisations and received continuous funding from the British Heart Foundation since 1997. He has published over 150 research articles (h index 33 and i10 index 64 with over 5500 citations). He is an Editorial Board member of 16 international journals; regular organising committee member, speaker and track/session chair at international conferences on heart disease; involved in grant evaluation for over 20 organisations; and supervised over 25 PhD students. In addition to research, he is involved in teaching and administration, including Postgraduate Tutor for the Biomedicine division at the School of Biosciences and external examiner for Biochemistry and Biomedical Sciences at the University of Reading and Kings College London.
Dipak Ramji(Research Area)
His research is focused on understanding how the immune and inflammatory responses regulate cellular processes in heart disease with the goal of attaining deeper mechanistic insight and identifying preventative/therapeutic agents.
University of Pisa
Francesco Lippi is a Professor of Endocrinology of School of Endocrinology of Pisa, Pisa, Italy. He is a director of Medical Assistance and Management of Thyroid Diseases (www.centrocuradellatiroide.it). He completed his M. D. degree, University of Pisa Medical School, 1978; Specialty degree, University of Pisa Postgraduate School of Endocrinology, 1983; Speciality degree, University of Florence Postgraduate School of Nuclear Medicine, 1987; specialty certification: Endocrinology, University of Pisa, 1983; speciality certification: Nuclear Medicine, University of Florence, 1987. His academic appointments and professional positions includes Medical Intern, Cattedra di Patologia Medica 2, University of Pisa; Assistant Professor, Institute of Endocrinology, University of Pisa; Coordinator of the Nuclear Medicine Service, Department of Endocrinology, University of Pisa; Professor of Endocrinology at the Postgraduate School of Endocrinology, Department of Endocrinology and Metabolism, University of Pisa. His memberships includes Italian Society of Endocrinology, Ordinary Member from 1989; European Thyroid Association, Ordinary Member from 1991; Italian Society of Nuclear Medicine, Ordinary Member from 1997; Endocrine Society, Ordinary Member from 1997; American Thyroid Association, Correspondent Member from 1997.
Francesco Lippi(Research Area)
His research interest focuses on thyroid diseases.
Professor and Chief Physician
Capital Medical University
Shen Yuan Yuan(Biography)
Shenyuan Yuan, Professor and Chief physician of Internal Medicine, Beijing Tongren Hospital, Capital Medical University. I graduated from Peking University Dept.of Medicine in 1955 and get MD&BS. I have been engaged in medical career for 62 years. I served as Director of Internal Medicine, Director of Digestive Science, and Director of Endocrinology in Beijing Tongren Hospital. I was the first head of the Beijing Diabetes Prevention and Treatment Office. I was Vice Chairman of Chinese Society on Microcirculation, Special member of European Society on Microcirculation, Director of Beijing Society of Digestion, CMA. I have won 21 awards, including the first Prize, the second prize and the third prize of Beijing Municipal Science and Technology Progress. 23 postgraduate students were trained under my guidance. In 1990, I enjoyed the Special Allowance of the State Council, and awarded as outstanding contribution expert in Beijing. Since 1996, I have carried out medical consultation work in communities for 22 years. I assisted in the establishment of Diabetes Prevention and Treatment Centers in Chaoyang district, Fengtai district, Mentougou district, Changping district, Daxing district and Yanqing district in Beijing. Now, I am principal leader of Beijing Community Diabetes Study (â€œBCDSâ€, 2008-2018) and the BRIDGES project from the International Diabetes Federation.
Shen Yuan Yuan(Research Area)
Her research interest focuses on Diabetes.
Professor and Chief Physician
Capital Medical University
Mingxia Yuan is a Professor, Chief Physician, vice-Director in the Department of Endocrinology, Beijing Tongren Hospital, Capital Medical University. She completed her MD (2000-2003) in Peking University Health Science Center. In 2004, she completed her GCP Training in Peking University. She was a collaborative partner in Rabin Medical Center, Tel Aviv, Israel for the year 2005 to 2006. She is a visiting scholar in Section on Nephrology, Centers for Genomics and Personalized Medicine Research & Diabetes Research, Wake Forest University Health Sciences, North Carolina Baptist Hospital, USA. Her Board Certification and Social Responsibilities includes Beijing Society of Endocrinology (2017ï½ž2020); Endocrinology and Metabolism of Gerontological Society of China (GSC) (2012ï½ž2020); Chinese Journal of Diabetes, editorial board member (2012ï½ž2020); International Diabetes, editorial board member (2010ï½ž2020).
Mingxia Yuan(Research Area)
Her research interest focuses on Diabetes.
Serbian Medical Society
Nikola M. Pavlovic(Biography)
Professor Nikola M. Pavlovic has graduated at the Medical Faculty, University Nis, Serbia in 1974, and become BMedSci 1979, Lecturer in Internal Medicine 1979, Specialist in Internal Medicine 1982, PhD of Medical Sciences 1986, and Associate Professor in Internal Medicine1988. British Council Scholar, Research Fellow, October 1982 â€“ June 1984 at the Department of Renal and Nephrology Services, Royal Free Hospital, London, UK. As the Research Fellow, he was doing clinical and experimental work aimed at looking at the role of lipids in the initiation and the progression of renal diseases. Professor Pavlovicâ€™s topics in research are renal bone disease, the role of lipids in the initiation and the progression of renal diseases, and the role of environmental factors (Aristolochic acids, PAHs) in the aetiology of renal diseases and attendant upper urothelial cancers. He has a long-standing interest in looking at the clinical and epidemiologic characteristics of BEN and has the vast experience and expertise in diagnosis and treatment of renal and disorders in hemodialysis and peritoneal dialysis patients. He is an experienced Specialist in Internal Medicine and Nephrology with a demonstrated history of working in the research industry. He is Skilled in Research, Clinical Research, and Customer Service. Strong professional graduated from Medical Faculty, University of Nis, Serbia. His recently published article entitled â€œQuantitation of Aristolochic Acids in Corn, Wheat Grain, and Soil Samples Collected in Serbia: Identifying a Novel Exposure Pathway in the Etiology of Balkan Endemic Nephropathyâ€ was selected for the 2017 Journal of Agricultural and Food Chemistry Research Article of the Year Award (AGRO division, American Chemical Society).
Nikola M. Pavlovic(Research Area)
Professor Pavlovic topics in research are renal bone disease, the role of lipids in the initiation and the progression of renal diseases, and the role of environmental factors (Aristolochic acids, PAHs) in the aetiology of renal diseases and attendant upper urothelial cancers. He has a long-standing interest in looking at the clinical and epidemiologic characteristics of BEN and has the vast experience and expertise in diagnosis and treatment of renal and disorders in hemodialysis and peritoneal dialysis patients. He is an experienced Specialist in Internal Medicine and Nephrology with a demonstrated history of working in the research industry. He is Skilled in Research, Clinical Research, and Customer Service. Strong professional graduated from Medical Faculty, University of Nis, Serbia.
Moscow State Medical University
Sergey Suchkov, M, PhD, is a Professor in Immunology, Dept of Pathology, School for Pharmacy, First Moscow State Medical University; a Dean of the Department (Faculty) of The PPPM Development, and the First Vice-President of the University of World Business, Politics and Law; Secretary General, United Cultural Convention (UCC), Cambridge, UK to cover a lot of responsibilities including research in the area of mechanisms of chronization, intertalks between innate and adaptive immunity, and interdisciplinary (medical, bioethical, economical, social and politicxal) issues covering PPPM. Dr Suchkov has been collaborating with scientists from USA, Japan, Germany, Israel and other countries to set up a new brand in the modern medicine,i.e., PPPM. In 1991-1998, He is a CoSupervisor over the Russian-American Agreement on scientific and clinical collaboration in the field of ocular immunology between Russian Academy of Sciences and National Institutes of Health (NIH); in 1991-1995, a member of The Reciprocal Exchange Fellowship Program between Russian Immunological Society and British Society for Immunology. He is an author of more than 500 publications including 10 patents and more than 10 monographs, handbooks and textbooks published in Russia and USA. He is a Supervisor for 18 dissertations maintained including 14 Candidates and 4Doctors of Science. At present, 10 dissertaions are being supervised by him. He is a member of the New York Academy of Sciences, ACS, AHA, EPMA, ARVO, ISER. He is a member of the Editorial Boards of Open Journal of Immunology, EPMA Journal, American J. of Cardiovascular Research & Personalized Medicine Universe.
Sergey Suchkov(Research Area)
His research interest focuses on Immunology.
Jose R. Reyes Memorial Medical Center
Higinio T Mappala (Biography)
Higinio T. Mappala is a distinguished physician and gifted medical researcher with 30 years of clinical experience, as well as a prolific communicator and lecturer in both academic and clinical fora. A board-certified specialist in Internal Medicine with board-certified subspecialties in Gastroenterology, Endoscopy, Clinical Toxicology and Pharmacology, and Clinical Nutrition. He is University Professor, a Dean of the School of Medicine, and Administrator at the undergraduate, graduate, and postgraduate levels; an author of more than 50 scientific papers. As a prolific lecturer, he has been a Focused lecturer on NAFLD for more than 10 years
Higinio T Mappala (Research Area)
His research area focuses on Non-alcoholic Fatty Liver Disease (NAFLD).
Lecturer and Associate Cheif Physician
Capital Medical University
Xue-lian Zhang, Associate Chief Physician of Endocrinology, Ph. D., Lecturer, Director Assistant of Dept. of Endocrinology, Beijing Tongren Hospital, Capital Medical University. I served as member of Endocrinology and Metabolism of Gerontological Society of China and Academic Working Committee on Islet Metabolism of China. I engaged in clinical work in the field of endocrinology. I studied in Department of Physiology, Chinese University of Hong Kong (2005-2006). I am the Principal Investigator of National Natural Science Foundation of China (NSFC) (81300726, 2014-2016) and Beijing Municipal Science &Technology Commission (Z151100004015021, 2015-2018). Participate in National Key Research and Development Plan of China; Participate in a number of National Natural Science Foundation of China (NSFC) (30671001, 30871187, 81355437, 81070644) and International Multi-Center Large-Scale Clinical Trials. Oral Presentation at National Annual Conferences of China (2003, 2006, 2010, 2013, 2014), 2nd International Conference on Chronic Diseases (2018) and WONCA (2018). Poster Presentation at EASD (2014), International Forum on Quality and Safety in Healthcare: Asia (2015) and ADA (2018). I have the certificate of the Ministry of Education of China for the Completion of Scientific and Technological Achievements. Published more than 30 articles ( Nature Communications, Therapeutics and Clinical Risk Management, Biochemical and Biophysical Research Communications, Endocrine Research, Diabetic Medicine, etc).
Xue-lian Zhang(Research Area)
Endocrine Research, Diabetic Medicine
University of Palermo,
Corrao Salvatore, Associate Professor, University of Palermo. Member of the Biomedical DPT of Internal and Specialistic Medicine, Director of C.R.E.A.M. (Interdipartimental Center of Research for effectiveness and appropriateness in medicine), Director of Internal Medicine II and Reumatology Complex Unit, ARNAS Civico, Di Cristina e Benfratelli, Palermo. Ad Interim Director of Infectious Disease Complex Unit, Long-term hospitalization Complex Unit, ARNAS Civico, Di Cristina e Benfratelli, Palermo. Director of Internal Medicine DPT with Rheumatology, Dermatology, Geriatric and Rehabilitation Service, ARNAS Civico, Di Cristina e Benfratelli, Palermo. He completed degree in Medicine and surgery at University of Palermo, masters in Business Management and specilaization in Internal Medicine.
Corrao Salvatore(Research Area)
His research includes area includes approach to the clinical complexity of the patient internship HTA corporate reporting systems and mid-analysis, Research methodology, Evidence based medicine, Advanced statistical analysis, Biomedical information research and knowledge management, Organizational models for the improvement of health processes Clinical, organizational and organizational decision making strategic.